Trials / Completed
CompletedNCT00015171
Buprenorphine and Naloxone for the Treatment of Opiate Dependence - 1
CS1008 A&B Eff/Safety Trial of BUP/NX for the Treatment of Opiate Dependence
- Status
- Completed
- Phase
- Phase 3
- Study type
- Interventional
- Enrollment
- 0 (planned)
- Sponsor
- National Institute on Drug Abuse (NIDA) · NIH
- Sex
- All
- Age
- 18 Years – 59 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is the use of buprenorphine/naloxone in treatment of opioid dependence.
Detailed description
The objective of this study is to determine the safety and efficacy of a buprenorphine/naloxone combination tablet for opiate dependence treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Buprenorphine/naloxone |
Timeline
- Start date
- 1996-04-01
- Primary completion
- 1997-05-01
- Completion
- 1997-06-01
- First posted
- 2001-04-18
- Last updated
- 2017-01-16
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00015171. Inclusion in this directory is not an endorsement.